Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00359099 · ClinicalTrials.gov registry record
Hepatitis C in Adults Who Underwent Congenital Heart Surgery Before Screening
A clinical trial, sponsored by Emory University.
- Terminated
- Registry status
- 1,000
- Enrollment target
NCT00359099 is a clinical trial that was terminated before completion, run by Emory University. The registered enrollment target is 1,000 participants.
The verdict
NCT00359099 was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
This is a retrospective chart review. We hypothesize that patients who have undergone congenital heart surgery, prior to screening of blood products have a significant risk of hepatitis C infection and all such patients would benefit from screening for hepatitis C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 1980-01 |
| Est. Completion | 2006-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00359099
The ClinicalTrials.gov registry entry for NCT00359099 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00359099 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00359099 about?
NCT00359099 is a clinical study titled "Hepatitis C in Adults Who Underwent Congenital Heart Surgery Before Screening". This is a retrospective chart review. We hypothesize that patients who have undergone congenital heart surgery, prior to screening of blood products have a significant risk of hepatitis C infection and all such patients would benefit from screening for hepatitis C.
What is the current status of trial NCT00359099?
This trial is currently terminated. The enrollment target is 1,000 participants. The study started on 1980-01. Estimated completion is 2006-07.
Who is sponsoring clinical trial NCT00359099?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.